Edesa Biotech Stock Analysis

Edesa Stock Analysis Notes

About 33.0% of the company shares are held by company insiders. The book value of Edesa Biotech was currently reported as 0.88. The company recorded a loss per share of 19.78. Edesa Biotech last dividend was issued on the 10th of June 2019. The entity had 1:7 split on the 11th of October 2023. Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada. Edesa Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. To learn more about Edesa Biotech call MD FRCPC at 289 800 9600 or check out https://www.edesabiotech.com.

Edesa Biotech Investment Alerts

Edesa Biotech Upcoming and Recent Events

Edesa Largest EPS Surprises

View All Earnings Estimates

Edesa Biotech Environmental, Social, and Governance (ESG) Scores

Edesa Biotech Thematic Classifications

Edesa Stock Institutional Investors

Note, although Edesa Biotech's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Edesa Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.47 M.

Edesa Profitablity

Management Efficiency

Edesa Biotech has return on total asset (ROA) of (0.7152) % which means that it has lost $0.7152 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2929) %, meaning that it created substantial loss on money invested by shareholders. Edesa Biotech's management efficiency ratios could be used to measure how well Edesa Biotech manages its routine affairs as well as how well it operates its assets and liabilities. As of November 29, 2024, Return On Tangible Assets is expected to decline to -0.61. In addition to that, Return On Capital Employed is expected to decline to -0.46. At present, Edesa Biotech's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 209.5 K, whereas Total Assets are forecasted to decline to about 8.7 M.

Technical Drivers

As of the 29th of November, Edesa Biotech shows the Standard Deviation of 4.16, mean deviation of 2.94, and Variance of 17.34. Edesa Biotech technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Edesa Biotech Price Movement Analysis

Edesa Biotech Insider Trading Activities

Edesa Biotech Outstanding Bonds

Edesa Biotech Predictive Daily Indicators

Edesa Biotech Corporate Filings

Edesa Biotech Forecast Models

Edesa Biotech's time-series forecasting models are one of many Edesa Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Edesa Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Edesa Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Edesa shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Edesa Biotech. By using and applying Edesa Stock analysis, traders can create a robust methodology for identifying Edesa entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Edesa analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Edesa analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Edesa Biotech stock analysis indicators help investors evaluate how Edesa Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Edesa Biotech shares will generate the highest return on investment. By understating and applying Edesa Biotech stock analysis, traders can identify Edesa Biotech position entry and exit signals to maximize returns.

When running Edesa Biotech's price analysis, check to measure Edesa Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edesa Biotech is operating at the current time. Most of Edesa Biotech's value examination focuses on studying past and present price action to predict the probability of Edesa Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edesa Biotech's price. Additionally, you may evaluate how the addition of Edesa Biotech to your portfolios can decrease your overall portfolio volatility.